Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

NCT06176885 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
36
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

yue junhan